Komentář ke studii LEADER
| Title in English | Commentary on the LEADER study |
|---|---|
| Authors | |
| Year of publication | 2017 |
| Type | Article in Proceedings |
| Conference | Diabetologie 2017 |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | diabetes mellitus; cardiovascular safety |
| Description | LEADER study investigates cardiovascular safety of liraglutide in patients with diabetes mellitus, and cardiovascular disease or at risk thereof. Study has proved the drug efficacy as well as the safety of its administration, including reduction of all-cause mortality. |